Form 4: Director Robert Ephron Granted TAOX Stock Options

Director Robert Ephron of TAO Synergies Inc. was granted 10,000 stock options with an exercise price of $4.80.

Summary

• Director Robert Ephron received a grant of 10,000 stock options for TAO Synergies Inc. (TAOX) common stock.
• The options have an exercise price of $4.80 per share.
• The grant date for these options is May 18, 2026.
• The options are set to expire on May 18, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the exercise of these options.

Risks

• Market price volatility could impact the value of the options and the incentive structure for the director.

Future Outlook

The options vest and become exercisable upon the completion of one year of service following May 18, 2026.

Management Comments

• No specific management commentary provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment with shareholder interests.

Comparison to Industry Standards

• The use of time-based vesting (one year) is consistent with standard corporate governance practices for non-employee director compensation.
• The 10-year expiration term is a standard industry practice for executive and director stock option plans.

Corporate Governance

Stakeholder Impact

• Shareholders may experience minor dilution if options are exercised in the future.

Next Steps

• Director to complete one year of service to trigger the vesting of the granted options.

Key Dates

Keywords

TAOX, TAO Synergies Inc., Form 4, Director Compensation, Stock Options, Insider Trading